Evidence map›Paper›PMID 40092500›Full record

ArticlePlastic and reconstructive surgery. Global open2025

Use of TIGR Synthetic Reabsorable Mesh in Primary Breast Reconstruction.

Will Fairman, Jonathan Nguyen

Abstract read
In one paragraph

Article in Plastic and reconstructive surgery. Global open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Will FairmanFrom the Private Practice, Atlanta, GA.
Jonathan NguyenFrom the Private Practice, Atlanta, GA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: In postmastectomy prosthetic breast reconstruction, materials such as acellular dermal matrix and synthetic meshes are used to support the implant or expander. The authors present a retrospective review of a synthetic TIGR mesh in primary prepectoral breast reconstruction while evaluating safety outcomes. Methods: This is a retrospective single-surgeon series of adult female cancer patients who underwent TIGR single-stage direct-to-implant reconstruction or 2-stage tissue expander reconstruction with the use of TIGR mesh. Surgical complications including surgical site infection, wound dehiscence, mastectomy flap necrosis, hematoma or seroma requiring operative intervention, and reconstructive failure were monitored. Results: A total of 49 patients with 86 breast reconstructions were included in the study. All patients had unilateral cancer and underwent reconstruction between May 2023 and March 2024. There were 37 (75.5%) bilateral mastectomies with reconstruction and 12 (24.5%) unilateral mastectomies with reconstruction. The average age of patients was 53.5 years (range: 32-77 y) and body mass index was 25 kg/m Conclusions: We have shown that TIGR mesh has acceptable short-term outcomes in both single-stage and 2-stage implant-based primary breast reconstruction. Future studies should investigate its long-term efficacy, safety, and cost against comparable products.

Identifiers

PMID40092500
PMCPMC11908751

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.